Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Educational Status × Clear all

Phase

Status

Completed 3 Active not recruiting 3 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 9 Prostatic Neoplasms 8 Breast Neoplasms 8 Colorectal Neoplasms 5 Anatomic Stage I Breast Cancer AJCC v8 3 Melanoma 2 Hematopoietic and Lymphatic System Neoplasm 2 Hematologic Neoplasms 2 Chronic Pain 2 Venous Thrombosis 1 Venous Thromboembolism 1 Sunburn 1 Spondylitis, Ankylosing 1 Skin Neoplasms 1 Sarcoma 1 Pulmonary Embolism 1 Psoriasis 1 Overweight 1 Obesity 1 Neoplastic Syndromes, Hereditary 1 Neoplasms 1 Neoplasm Metastasis 1 Malignant Solid Neoplasm 1 Lymphoma 1 Lupus Erythematosus, Systemic 1 Inflammatory Bowel Diseases 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematopoietic Cell Transplantation Recipient 1 Glioblastoma 1 Gastrointestinal Neoplasms 1

Interventions

Cyclophosphamide 26 fludarabine 18 Rituximab 13 obinutuzumab 10 Bendamustine Hydrochloride 9 venetoclax 7 Lenalidomide 7 pembrolizumab 5 Prednisone 5 Exercise 5 zanubrutinib 4 fludarabine phosphate 4 Mesna 4 Etoposide 4 Doxorubicin 4 Cytarabine 4 Blood Specimen Collection 4 Biopsy 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 Vincristine 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Radiotherapy 3 Palliative Care 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006482 2026-01-13

GEM-S

University of Rochester

Phase 3 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡